Michael Vaezi Archive — Page 1 of 1

(iStock)
February 26, 2020

Potential new heartburn drug studied at VUMC

An investigational drug that binds bile acids in the stomach can reduce the severity of heartburn symptoms in patients with treatment-resistant gastroesophageal reflux disease (GERD) when combined with a proton pump inhibitor (PPI), a new study suggests.

By Bill Snyder
Two men sit in a clinical office beside a computer monitor; one gestures while the other listens. The monitor displays text too small to read.
April 13, 2017

Trial to test implantable device to ease gastroesophageal reflux

For more than a dozen years Buz Harrison, a Nashville-based media producer, has been plagued by gastroesophageal reflux disease (GERD).

By Bill Snyder